The Activation Pattern of Blood Leukocytes in Head and Neck Squamous Cell Carcinoma Is Correlated to Survival

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Millrud, Camilla Rydberg ^a   Månsson Kvarnhammar, Anne ^a   Uddman, Rolf ^b   Björnsson, Sven ^c   Riesbeck, Kristian ^c   Cardell, Lars Olaf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CD98 ANTIGEN; L SELECTIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CD4 CD8 RATIO; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPH NODE; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES; MALE; SURVIVAL ANALYSIS;

EID: 84870914865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051120     Document Type: Article

References (29)

1. Pries R, Nitsch S, Wollenberg B, (2006) Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 6: 1195-1203.
2. Woods KV, El-Naggar A, Clayman GL, Grimm EA, (1998) Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58: 3132-3141.
3. Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R, (2008) Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Cancer Immun 8: 10.
4. Aarstad HJ, Heimdal JH, Klementsen B, Olofsson J, Ulvestad E, (2006) Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Otolaryngol 126: 1326-1333.
5. Heimdal JH, Aarstad HJ, Olofsson J, (2000) Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Laryngoscope 110: 402-407.
6. Xie L, Pries R, Kesselring R, Wulff S, Wollenberg B, (2007) Head and neck cancer triggers the internalization of TLR3 in natural killer cells. Int J Mol Med 20: 493-499.
7. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL, (2004) Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10: 3755-3762.
8. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, et al. (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58: 15-23.
9. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ, (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181-184.
10. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, et al. (2008) Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34: 55-60.
11. Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H, (1998) The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 124: 329-334.
12. Karlsson M, Lindberg K, Karlen P, Ost A, Thorn M, et al. (2010) Evidence for immunosurveillance in intestinal premalignant lesions. Scand J Immunol 71: 362-368.
13. Giuntoli RL 2nd, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, et al. (2009) Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res 29: 2875-2884.
14. da Silveira EJ, Miguel MC, Lima KC, Freitas Rde A, de Morais Mde L, et al. (2010) Analysis of local immunity in squamous cell carcinoma of the tongue and lower lip. Exp Mol Pathol 88: 171-175.
15. Boucek J, Mrkvan T, Chovanec M, Kuchar M, Betka J, et al. (2009) Regulatory T cells and their prognostic value for patients with Squamous Cell Carcinoma of the Head and Neck. J Cell Mol Med.
16. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, et al. (1999) Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 86: 1537-1543.
17. Cho H, Kim JH, (2009) Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. Biomarkers 14: 161-170.
18. Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, et al. (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 93: 273-278.
19. Zahorec R, (2001) Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102: 5-14.
20. Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T, (2004) Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res 64: 1037-1043.
21. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH, (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6: 283-287.
22. Fridlender ZG, Albelda SM, (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33: 949-955.
23. Gregory AD, Houghton AM, (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71: 2411-2416.
24. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, et al. (2008) Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67: 152-159.
25. Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J, (1999) Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma. Eur Arch Otorhinolaryngol 256: 250-256.
26. Srivastava MK, Andersson A, Zhu L, Harris-White M, Lee JM, et al. (2012) Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy 4: 291-304.
27. Lathers DM, Achille NJ, Young MR, (2003) Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck. Hum Immunol 64: 1160-1166.
28. Herberman RB, Ortaldo JR, (1981) Natural killer cells: their roles in defenses against disease. Science 214: 24-30.
29. Bose A, Ghosh D, Pal S, Mukherjee KK, Biswas J, et al. (2006) Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling. Oral Oncol 42: 161-171.